Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

Clinical trial NCT01598103 · TERMINATED

Trial details

NCT number: NCT01598103
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurogenic Urinary Bladder Neurogenic Bladder Disorder Neurogenic Dysfunction of the Urinary Bladder Neurogenic Bladder, Uninhibited Neurogenic Bladder, Spastic

Start date: 2012-01-01
Primary completion: 2012-09-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.